npj Breast Cancer (Jul 2023)

Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial

  • Yang Yang,
  • Yingjian He,
  • Zhaoqing Fan,
  • Xue Chen,
  • Yiqiang Liu,
  • Chao Zhang,
  • Hongchuan Jiang,
  • Xin Wang,
  • Xiang Wang,
  • Fei Xie,
  • Shu Wang,
  • Bin Luo,
  • Hua Kang,
  • Tao Wang,
  • Zefei Jiang,
  • Peng Yuan,
  • Binhe Xu,
  • Ling Xu,
  • Yinhua Liu,
  • Jinfeng Li,
  • Yuntao Xie,
  • Tianfeng Wang,
  • Tao Ouyang

DOI
https://doi.org/10.1038/s41523-023-00567-6
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 1

Abstract

Read online

No abstracts available.